Latest news
Latest news
Manager trims spreads on CLO’s investment grade tranches in partial refinancing
New hire spent spent more than a decade at Arnold & Porter
Deal priced 1bp wide of Oaktree's previous new issue transaction
More articles
More articles
-
Continued pressure on equity investors means the European CLO market could be facing a muted second quarter, despite a recent flurry of deals in March, according to panellists at IMN’s Investors’ Conference on European CLOs and Leveraged Loans, held in London on Monday. -
Goldman Sachs has sold a $451.1 CLO for Canyon Advisors, closing out an otherwise quiet week for the primary CLO market.
-
Concerns are growing in the US CLO market about the state of pharmaceutical giant Valeant Pharmaceuticals, as the Canadian company's stock price continues to fall, touching the lowest levels in five years in March.
-
Trading in the US ABS secondary market in March has seen dealers further reduce their holdings across asset classes.
-
The US CLO market maintained its strong new issue momentum this week with seven deals priced, but concerns over price discovery and long-term conditions are affecting the mood and leading to wide disparities in spreads.
-
Two new CLOs have landed in the European CLO market, as arrangers take advantage of the market window to launch deals that have been languishing in warehouses for months.
-
The lower level of collateralised loan obligation issuance expected this year will create favourable conditions for debt funds, according to Lyxor Asset Management.
-
The primary CLO market in March has opened up, with three additional CLOs pricing to keep the March pipeline flowing.
-
Franklin Templeton Investments has launched a fixed income fund that will include a range of derivative strategies, other assets such as securitized products, and the ability to go long or short.
